The role of chemokines in human immunodeficiency virus infection

被引:36
作者
Garzino-Demo, A
DeVico, AL
Conant, KE
Gallo, RC
机构
[1] Univ Maryland, Inst Biotechnol, Inst Human Virol, Baltimore, MD 21201 USA
[2] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA
关键词
D O I
10.1034/j.1600-065X.2000.17711.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Chemokines that bind to human immunodeficiency virus (HIV) co-receptors are potent and selective inhibitors of HN infection. Therefore, ever since our discovery of this activity, we have proposed their role in controlling HIV infection as a third arm of the immune response, i.e. in concert with humoral and cellular responses. Research carried out in our laboratory and performed independently by other groups, has recently strengthened this concept. Here, we critically analyze the evidence indicating the positive contribution of chemokines to HN infection, their involvement with cognate and innate immunity, and the potential for their use in combating HIV infection.
引用
收藏
页码:79 / 87
页数:9
相关论文
共 86 条
[1]   β-chemokine production in macaques vaccinated with live attenuated virus correlates with protection against simian immunodeficiency virus (SIVsm) challenge [J].
Ahmed, RKS ;
Nilsson, C ;
Wang, YF ;
Lehner, T ;
Biberfeld, G ;
Thorstensson, R .
JOURNAL OF GENERAL VIROLOGY, 1999, 80 :1569-1574
[2]  
Aleman S, 1999, ANTIVIR THER, V4, P109
[3]   CC CKRS: A RANTES, MIP-1 alpha, MIP-1 beta receptor as a fusion cofactor for macrophage-tropic HIV-1 [J].
Alkhatib, G ;
Combadiere, C ;
Broder, CC ;
Feng, Y ;
Kennedy, PE ;
Murphy, PM ;
Berger, EA .
SCIENCE, 1996, 272 (5270) :1955-1958
[4]   The inhibitory effect of RANTES on the infection of primary macrophages by R5 human immunodeficiency virus type-1 depends on the macrophage activation state [J].
Amzazi, S ;
Ylisastigui, L ;
Bakri, Y ;
Rabehi, L ;
Gattegno, L ;
Parmentier, M ;
Gluckman, JC ;
Benjouad, A .
VIROLOGY, 1998, 252 (01) :96-105
[5]   Circulating levels of RANTES in human immunodeficiency virus type 1 infection:: Effect of potent antiretroviral therapy [J].
Aukrust, P ;
Müller, F ;
Froland, SS .
JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (04) :1091-1096
[6]   Change in circulating levels of the chemokines macrophage inflammatory proteins 1 alpha and 1 beta, RANTES, monocyte chemotactic protein-1 and interleukin-16 following treatment of severely immunodeficient HIV-infected individuals with indinavir [J].
Bisset, LR ;
Rothen, M ;
JollerJemelka, HI ;
Dubs, RW ;
Grob, PJ ;
Opravil, M .
AIDS, 1997, 11 (04) :485-491
[7]   A new monoclonal antibody, mAb 4A12, identifies a role for the glycosaminoglycan (GAG) binding domain of RANTES in the antiviral effect against HIV-1 and intracellular Ca2+ signaling [J].
Burns, JM ;
Gallo, RC ;
DeVico, AL ;
Lewis, GK .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (10) :1917-1927
[8]   Massive expansion of antigen-specific CD8+ T cells during an acute virus infection [J].
Butz, EA ;
Bevan, MJ .
IMMUNITY, 1998, 8 (02) :167-175
[9]   Molecular cloning and functional characterization of a novel CC chemokine, stimulated T cell chemotactic protein (STCP-1) that specifically acts on activated T lymphocytes [J].
Chang, MS ;
McNinch, J ;
Elias, C ;
Manthey, CL ;
Grosshans, D ;
Meng, T ;
Boone, T ;
Andrew, DP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (40) :25229-25237
[10]   The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates [J].
Choe, H ;
Farzan, M ;
Sun, Y ;
Sullivan, N ;
Rollins, B ;
Ponath, PD ;
Wu, LJ ;
Mackay, CR ;
LaRosa, G ;
Newman, W ;
Gerard, N ;
Gerard, C ;
Sodroski, J .
CELL, 1996, 85 (07) :1135-1148